Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.

Maura F, Agnelli L, Leongamornlert D, Bolli N, Chan WC, Dodero A, Carniti C, Heavican TB, Pellegrinelli A, Pruneri G, Butler A, Bhosle SG, Chiappella A, Di Rocco A, Zinzani PL, Zaja F, Piva R, Inghirami G, Wang W, Palomero T, Iqbal J, Neri A, Campbell PJ, Corradini P.

Am J Hematol. 2019 Jun;94(6):628-634. doi: 10.1002/ajh.25450. Epub 2019 Mar 19.

PMID:
30829413
2.

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma.

Dodero A, Guidetti A, Tucci A, Barretta F, Novo M, Devizzi L, Re A, Passi A, Pellegrinelli A, Pruneri G, Miceli R, Testi A, Pennisi M, Di Chio MC, Matteucci P, Carniti C, Facchetti F, Rossi G, Corradini P.

Leukemia. 2019 Apr;33(4):1047-1051. doi: 10.1038/s41375-018-0320-9. Epub 2019 Jan 10. No abstract available.

3.

Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas.

Mussetti A, Martinetti N, Cieri N, Pennisi M, Dodero A, Corradini P.

Bone Marrow Transplant. 2018 Dec 7. doi: 10.1038/s41409-018-0417-9. [Epub ahead of print]

PMID:
30531956
4.

A micro-rheological and rheological study of biopolymers solutions: Hyaluronic acid.

Dodero A, Williams R, Gagliardi S, Vicini S, Alloisio M, Castellano M.

Carbohydr Polym. 2019 Jan 1;203:349-355. doi: 10.1016/j.carbpol.2018.09.072. Epub 2018 Sep 28.

PMID:
30318222
5.

Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survival.

Spina F, Radice T, De Philippis C, Soldarini M, Di Chio MC, Dodero A, Guidetti A, Viviani S, Corradini P.

Leuk Lymphoma. 2019 Jan;60(1):101-109. doi: 10.1080/10428194.2018.1459607. Epub 2018 May 1.

PMID:
29716416
6.

Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports.

Grossi G, Viganò M, Facchetti F, Labanca S, Loglio A, Dodero A, Montefusco V, Corradini P, Cafro A, Cairoli R, Colombo M, Lampertico P.

Haematologica. 2017 Oct;102(10):e423-e426. doi: 10.3324/haematol.2017.168609. Epub 2017 Jun 28. No abstract available.

7.

Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen.

Dodero A, Patriarca F, Milone G, Sarina B, Miceli R, Iori A, Barretta F, Terruzzi E, Mussetti A, Pini M, Bosi A, Dominietto A, Cascavilla N, Onida F, Narni F, Farina L, Rambaldi A, Corradini P.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1102-1109. doi: 10.1016/j.bbmt.2017.03.031. Epub 2017 Apr 5.

8.

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression.

Maura F, Guidetti A, Pellegrinelli A, Dodero A, Pennisi M, Caprioli C, Testi A, Farina L, Bolli N, Devizzi LF, Cabras A, Corradini P.

Blood Cancer J. 2017 Mar 17;7(3):e544. doi: 10.1038/bcj.2017.25. No abstract available.

9.

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression.

Maura F, Guidetti A, Pellegrinelli A, Dodero A, Pennisi M, Caprioli C, Testi A, Farina L, Bolli N, Devizzi LF, Cabras A, Corradini P.

Blood Cancer J. 2016 Nov 4;6(11):e491. doi: 10.1038/bcj.2016.99. No abstract available. Erratum in: Blood Cancer J. 2017 Mar 17;7(3):e544.

10.

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients.

Pellegrini C, Dodero A, Chiappella A, Monaco F, Degl'Innocenti D, Salvi F, Vitolo U, Argnani L, Corradini P, Zinzani PL; Italian Lymphoma Foundation (Fondazione Italiana Linfomi Onlus, FIL).

J Hematol Oncol. 2016 Apr 12;9:38. doi: 10.1186/s13045-016-0266-1.

11.

Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.

Farina L, Rezzonico F, Spina F, Dodero A, Mazzocchi A, Crippa F, Alessi A, Dalto S, Viviani S, Corradini P.

Biol Blood Marrow Transplant. 2014 Dec;20(12):1982-8. doi: 10.1016/j.bbmt.2014.08.016. Epub 2014 Aug 23.

12.

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.

Guidetti A, Carlo-Stella C, Locatelli SL, Malorni W, Mortarini R, Viviani S, Russo D, Marchianò A, Sorasio R, Dodero A, Farina L, Giordano L, Di Nicola M, Anichini A, Corradini P, Gianni AM.

Clin Cancer Res. 2014 Nov 15;20(22):5641-51. doi: 10.1158/1078-0432.CCR-14-0770. Epub 2014 Sep 19.

13.

Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.

Montefusco V, Galli M, Spina F, Stefanoni P, Mussetti A, Perrone G, De Philippis C, Dalto S, Maura F, Bonini C, Rezzonico F, Pennisi M, Roncari L, Soldarini M, Dodero A, Farina L, Cocito F, Caprioli C, Corradini P.

Leuk Lymphoma. 2014 Sep;55(9):2032-7. doi: 10.3109/10428194.2014.914203. Epub 2014 Jun 5.

PMID:
24730540
14.

Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma.

Corradini P, Vitolo U, Rambaldi A, Miceli R, Patriarca F, Gallamini A, Olivieri A, Benedetti F, Todeschini G, Rossi G, Salvi F, Bruno B, Baldini L, Ferreri A, Patti C, Tarella C, Pileri S, Dodero A.

Leukemia. 2014 Sep;28(9):1885-91. doi: 10.1038/leu.2014.79. Epub 2014 Feb 20.

15.

Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.

Mariotti J, Maura F, Spina F, Roncari L, Dodero A, Farina L, Montefusco V, Carniti C, Sarina B, Patriarca F, Rambaldi A, Onida F, Olivieri A, Zallio F, Corradini P.

Biol Blood Marrow Transplant. 2014 Jun;20(6):885-90. doi: 10.1016/j.bbmt.2014.02.015. Epub 2014 Feb 28.

16.

Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor: an algorithm for the pre-emptive use of plerixafor.

Farina L, Spina F, Guidetti A, Longoni P, Ravagnani F, Dodero A, Montefusco V, Carlo-Stella C, Corradini P.

Leuk Lymphoma. 2014 Feb;55(2):331-6. doi: 10.3109/10428194.2013.802783. Epub 2013 Jun 14.

PMID:
23656194
17.

Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation.

Montefusco V, Spina F, Patriarca F, Offidani M, Bruno B, Montanari M, Mussetti A, Sperotto A, Scortechini I, Dodero A, Fanin R, Valagussa P, Corradini P.

Biol Blood Marrow Transplant. 2013 Mar;19(3):424-8. doi: 10.1016/j.bbmt.2012.10.032. Epub 2012 Nov 8.

18.

Phase II study of sorafenib in patients with relapsed or refractory lymphoma.

Guidetti A, Carlo-Stella C, Locatelli SL, Malorni W, Pierdominici M, Barbati C, Mortarini R, Devizzi L, Matteucci P, Marchianò A, Lanocita R, Farina L, Dodero A, Tarella C, Di Nicola M, Corradini P, Anichini A, Gianni AM.

Br J Haematol. 2012 Jul;158(1):108-19. doi: 10.1111/j.1365-2141.2012.09139.x. Epub 2012 May 10.

PMID:
22571717
19.

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.

Rigacci L, Puccini B, Dodero A, Iacopino P, Castagna L, Bramanti S, Ciceri F, Fanin R, Rambaldi A, Falda M, Milone G, Guidi S, Martelli MF, Mazza P, Oneto R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Ann Hematol. 2012 Jun;91(6):931-9. doi: 10.1007/s00277-011-1395-9. Epub 2012 Jan 14.

PMID:
22245922
20.

Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.

Dodero A, Spina F, Narni F, Patriarca F, Cavattoni I, Benedetti F, Ciceri F, Baronciani D, Scimè R, Pogliani E, Rambaldi A, Bonifazi F, Dalto S, Bruno B, Corradini P.

Leukemia. 2012 Mar;26(3):520-6. doi: 10.1038/leu.2011.240. Epub 2011 Sep 9.

21.

Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy.

Milazzo L, Corbellino M, Foschi A, Micheli V, Dodero A, Mazzocchi A, Montefusco V, Zehender G, Antinori S.

Transpl Infect Dis. 2012 Feb;14(1):95-8. doi: 10.1111/j.1399-3062.2011.00659.x. Epub 2011 Jul 12.

PMID:
21749588
22.

Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells.

Warncke M, Buchner M, Thaller G, Dodero A, Bulashevska A, Pfeifer D, Timmer J, Veelken H.

Cancer Immunol Immunother. 2011 Jan;60(1):49-60. doi: 10.1007/s00262-010-0918-x. Epub 2010 Sep 17.

23.

Merino sheep: a further look at quantitative trait loci for wool production.

Roldan DL, Dodero AM, Bidinost F, Taddeo HR, Allain D, Poli MA, Elsen JM.

Animal. 2010 Aug;4(8):1330-40. doi: 10.1017/S1751731110000315.

PMID:
22444653
24.

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation.

Dodero A, Crocchiolo R, Patriarca F, Miceli R, Castagna L, Ciceri F, Bramanti S, Frungillo N, Milani R, Crippa F, Fallanca F, Englaro E, Corradini P.

Cancer. 2010 Nov 1;116(21):5001-11. doi: 10.1002/cncr.25357.

25.

Nasal allergies in the Latin American population: results from the Allergies in Latin America survey.

Neffen H, Mello JF Jr, Sole D, Naspitz CK, Dodero AE, Garza HL, Guerra EN, Baez-Loyola C, Boyle JM, Wingertzahn MA.

Allergy Asthma Proc. 2010 May-Jun;31 Suppl 1:S9-27. doi: 10.2500/aap.2010.31.3347. Epub 2010 Jun 16.

PMID:
20557683
26.

Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation.

Farina L, Carniti C, Dodero A, Vendramin A, Raganato A, Spina F, Patriarca F, Narni F, Benedetti F, Olivieri A, Corradini P.

Haematologica. 2009 May;94(5):654-62. doi: 10.3324/haematol.2008.000273. Epub 2009 Apr 18.

27.

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.

Dodero A, Carniti C, Raganato A, Vendramin A, Farina L, Spina F, Carlo-Stella C, Di Terlizzi S, Milanesi M, Longoni P, Gandola L, Lombardo C, Corradini P.

Blood. 2009 May 7;113(19):4771-9. doi: 10.1182/blood-2008-10-183723. Epub 2009 Feb 11.

28.

Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.

Corradini P, Dodero A, Farina L, Fanin R, Patriarca F, Miceli R, Matteucci P, Bregni M, Scimè R, Narni F, Pogliani E, Locasciulli A, Milani R, Carniti C, Bacigalupo A, Rambaldi A, Bonifazi F, Olivieri A, Gianni AM, Tarella C; Gruppo Italiano Trapianto di Midollo Osseo.

Leukemia. 2007 Nov;21(11):2316-23. Epub 2007 Jun 28.

PMID:
17597807
29.

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.

Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P, Gianni AM, Rambaldi A, Barbui T, Cortelazzo S.

Leukemia. 2006 Sep;20(9):1533-8. Epub 2006 Jul 27.

PMID:
16871285
30.

Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses.

Warncke M, Dodero A, Dierbach H, Follo M, Veelken H.

J Immunol Methods. 2006 Mar 20;310(1-2):1-11. Epub 2005 Oct 25.

PMID:
16337648
31.

Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.

Corradini P, Zallio F, Mariotti J, Farina L, Bregni M, Valagussa P, Ciceri F, Bacigalupo A, Dodero A, Lucesole M, Patriarca F, Rambaldi A, Scimè R, Locasciulli A, Bandini G, Gianni AM, Tarella C, Olivieri A.

J Clin Oncol. 2005 Sep 20;23(27):6690-8.

PMID:
16170177
32.

Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.

Dodero A, Carrabba M, Milani R, Rizzo E, Raganato A, Montefusco V, Farina L, Milanesi M, Longoni P, Carlo-Stella C, Corradini P.

Exp Hematol. 2005 Aug;33(8):920-7.

PMID:
16038785
33.

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M, Narni F, Patriarca F, Boccadoro M, Benedetti F, Rambaldi A, Gianni AM, Tarella C.

J Clin Oncol. 2004 Jun 1;22(11):2172-6.

PMID:
15169805
34.

P-CHOP: cisplatin (P) added to the standard CHOP regimen as first-line treatment for aggressive non-Hodgkin lymphoma: a single-institution phase II study.

Cocconi G, Franciosi V, Dodero A, Bologna A, Vasini G, De Lisi V, Di Blasio B, Ceci G, Camisa R, Cascinu S.

Am J Clin Oncol. 2003 Dec;26(6):535-42.

PMID:
14663368
35.

Clinical and molecular remission following reduced intensity conditioning and allogeneic transplantation in a patient with refractory multiple myeloma.

Dodero A, Perfetti V, Ciceri F, Corradini P.

Haematologica. 2002 Dec;87(12):ECR41. No abstract available.

PMID:
12495912
36.

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer.

Bregni M, Dodero A, Peccatori J, Pescarollo A, Bernardi M, Sassi I, Voena C, Zaniboni A, Bordignon C, Corradini P.

Blood. 2002 Jun 1;99(11):4234-6.

37.

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.

Corradini P, Tarella C, Olivieri A, Gianni AM, Voena C, Zallio F, Ladetto M, Falda M, Lucesole M, Dodero A, Ciceri F, Benedetti F, Rambaldi A, Sajeva MR, Tresoldi M, Pileri A, Bordignon C, Bregni M.

Blood. 2002 Jan 1;99(1):75-82.

38.

Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.

Bregni M, Siena S, Di Nicola M, Dodero A, Peccatori F, Ravagnani F, Danesini G, Laffranchi A, Bonadonna G, Gianni AM.

J Clin Oncol. 1996 Feb;14(2):628-35.

PMID:
8636780
39.

[Clinical aspects and diagnosis of neonatal infections caused by group B beta-hemolytic Streptococcus].

Bellettato M, Caccamo ML, Cantarutti F, D'Antonio G, Dodero A, Giana G, Gorinati M, Mantegazza M, Marcon R, Meneghetti S, et al.

Pediatr Med Chir. 1995 Jul-Aug;17(4):299-302. Italian.

PMID:
7491322
40.

Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells.

Di Nicola M, Siena S, Bregni M, Ravagnani F, Vitello F, Belli N, Dodero A, Magni M, Bonadonna G, Gianni AM, et al.

Bone Marrow Transplant. 1994 Dec;14(6):863-9. Erratum in: Bone Marrow Transplant 1995 Aug;16(2):327.

PMID:
7536068
41.

[Postpartum adaptation of naturally delivered newborn infants. Preliminary results].

Gorinati M, Patelli P, Dodero A, Semini E.

Pediatr Med Chir. 1992 Jan-Feb;14(3-6 Suppl):63-4. Italian.

PMID:
1589340
42.

Inv dup (8) (p21.1----22.1): further case report and a new hypothesis on the origin of the chromosome abnormality.

Gorinati M, Caufin D, Minelli A, Memo L, Gaspardo G, Dodero A.

Clin Genet. 1991 Jan;39(1):55-9.

PMID:
1997216
43.

[Traumatic pseudodiverticulum of the esophagus. Description of a case in a preterm newborn infant].

Gorinati M, Dodero A, Semini V, Uzzielli G, Maso R, Perrino GP.

Pediatr Med Chir. 1990 Mar-Apr;12(2):207-9. Italian.

PMID:
2122420
44.

Terminal deletion of the long arm of chromosome 10: case report and review of the literature.

Gorinati M, Zamboni G, Padoin N, Dodero A, Caufin D, Memo L.

Am J Med Genet. 1989 Aug;33(4):502-4. Review.

PMID:
2688417
45.

[Periventricular leukomalacia in the newborn infant. Clinical and echographic diagnosis and follow-up].

Gorinati M, Dodero A, Da Re R, Pellegri A, Semini V.

Pediatr Med Chir. 1988 Jan-Feb;10(1):55-61. Italian.

PMID:
3287350

Supplemental Content

Loading ...
Support Center